Propanc Biopharma, Inc. Common Stock (PPCB PINK) stock market data APIs
$2.2106
-0.04(-1.8%)
as of September 12, 2025
Try our APIs with
free plan!
Propanc Biopharma, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
Prev. Close
2.2106
Open
2.1659
High
2.5097
Low
2.1043
52 wk Range
1.6-30
Market Cap
27 998 K
Shares Outstanding
12 612 K
EPS
-12.5
Beta
19897.537
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Propanc Biopharma, Inc. Common Stock data using free add-ons & libraries
Get Propanc Biopharma, Inc. Common Stock Fundamental Data
Propanc Biopharma, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -53 892 560
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-15
- EPS/Forecast: NaN
Get Propanc Biopharma, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Propanc Biopharma, Inc. Common Stock News
New
Propanc Biopharma announces plan to acquire $100 million of Ethereum
* Propanc Biopharma (NASDAQ:PPCB [https://seekingalpha.com/symbol/PPCB]) announced on Tuesday a plan to acquire $100 million of Ethereum over the next 12 months. * "The strategic purchase of Ether...
Propanc Biopharma Provides Shareholder Update
MELBOURNE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments fo...
Propanc Biopharma closes public offering, uplists to NASDAQ
* Propanc Biopharma (NASDAQ:PPCB [https://seekingalpha.com/symbol/PPCB]) on Tuesday said that it closed an underwritten public offering of 1,000,000 shares of its common stock, at $4.00 per share fo...
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
MELBOURNE, Australia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments fo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
